OTCQX:MRVFF - Post by User
Comment by
lscfaon Feb 25, 2020 9:13am
142 Views
Post# 30729944
RE:Great quarter and year end
RE:Great quarter and year end synergies of merger too....
ValueCap wrote:
8.6 million quarterly ebitda vs estimate 7.8. Annual ebitda 28.1 million vs 26.1 estimate
Great Blexten and Cambia growth.
Swiss approval of Pennsaid 2% and launch this year.
Anticipated Suvexx approval this year and launch in 3Q